K2LTS Telomerase Inhibitor by K2LT LAB, LLC 84429-003 Complete

K2LTS Telomerase Inhibitor by

Drug Labeling and Warnings

K2LTS Telomerase Inhibitor by is a Otc medication manufactured, distributed, or labeled by K2LT LAB, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

K2LTS TELOMERASE INHIBITOR- telomerase inhibitor liquid 
K2LT LAB, LLC

----------

84429-003 Complete

Active Ingredient

Ginsenoside 35mg(17.5%)

Purpose

For early stage cancer patients

Use

This product is suitable for patients with early-stage cancer.
Inhibits telomerase activity, thus preventing the proliferation and growth of tumor cells;
Stabilizing gene mutations and stabilizing chromosomes;

Warnings

Side Effects：Avoid concurrent use with other drugs.

Consult a doctor before use.

Do not use

This product may cause mild gastrointestinal discomfort, occasional allergicreactions.

This product contains Ginsenosides and EGCG extract. Do not use if you areallergic to these ingredients.

When Using

The concurrent use of drugs or increased exposure to this product may lead to clinically significant adverse reactions.

The concurrent use of drugs significantly reduces the concentration of this product, resulting in decrease of the therapeutic effect of the concurrent drugs used.

Stop Use

Stop use and ask a doctor if irritation or rash occurs

Ask Doctor

Stop use and ask a doctor if irritation or rash occurs

Keep Oot Of Reach Of Children

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Directions

Twist the cap and administrate directly. Twice a day. Do not exceed the recommended dosage.

Other information

Storage Method：The product should be stored in a cool, dry, and dark environment with a temperature range of 16°C to 27°C(60-80℉), and humidity not exceeding 50%.

Inactive ingredients

EGCG 55mg, Sulforaphane 40mg, Ashitaba leaf extract 30mg, Ergothioneine 20mg, Cordycepin 10mg, Selenium 5mg.

Other ingredients

Sodium benzoate 3mg, Borneol 2mg.

PRINCIPAL DISPLAY PANEL

K2LTS TELOMERASE INHIBITOR 
telomerase inhibitor liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84429-003
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GINSENOSIDES (UNII: 3K198YD54P) (GINSENOSIDES - UNII:3K198YD54P)	GINSENOSIDES	17.5 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ERGOTHIONEINE (UNII: BDZ3DQM98W)
EPIGALLOCATECHIN GALLATE (UNII: BQM438CTEL)
ANGELICA KEISKEI TOP (UNII: AP628M4TQO)
CORDYCEPIN (UNII: GZ8VF4M2J8)
SULFORAPHANE (UNII: GA49J4310U)
SODIUM BENZOATE (UNII: OJ245FE5EU)
BORNEOL (UNII: M89NIB437X)
SELENIUM (UNII: H6241UJ22B)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84429-003-01	60 mL in 1 BOX; Type 0: Not a Combination Product	09/11/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M022	09/11/2024	01/28/2026

Labeler - K2LT LAB, LLC (072189878)

Establishment
Name	Address	ID/FEI	Business Operations
K2LT LAB, LLC		072189878	manufacture(84429-003)

Revised: 1/2026

Document Id: 496a00b2-02da-55c7-e063-6394a90a6b50

34390-5

Set id: 21cfc51f-1f4a-b7f1-e063-6294a90a1cbd

Version: 2

Effective Time: 20260127